Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Book a Free Consultation
Typically, your healthcare professional submits paperwork on your behalf to inform the insurance provider of the necessity of the medication for your medical needs
WADA status: As of the 2026 WADA Prohibited List, BPC-157 is classified under S0: Non-Approved Substances, prohibited in-competition and out-of-competition at all times
They are not interchangeable unless specifically indicated by research protocols
The largest trial involving DSIP to date, which included a total of 107 volunteers, reported that the peptide was generally well-tolerated with mostly minor side effects, which included [8]: Low blood pressure Increased sweating Headache Nausea Vertigo Considering that the drop in blood pressure was reported as moderate to severe in some patients, researchers should consider hypotension as a potentially exclusionary criterion for DSIP research
US$ 22.35
US$ 26.72
US$ 24.20
